Cargando…

Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids

Detalles Bibliográficos
Autores principales: Miyakawa, Kei, Machida, Masakazu, Kawasaki, Tomoyuki, Nishi, Mayuko, Akutsu, Hidenori, Ryo, Akihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052787/
https://www.ncbi.nlm.nih.gov/pubmed/35500619
http://dx.doi.org/10.1053/j.gastro.2022.04.043
_version_ 1784696857325207552
author Miyakawa, Kei
Machida, Masakazu
Kawasaki, Tomoyuki
Nishi, Mayuko
Akutsu, Hidenori
Ryo, Akihide
author_facet Miyakawa, Kei
Machida, Masakazu
Kawasaki, Tomoyuki
Nishi, Mayuko
Akutsu, Hidenori
Ryo, Akihide
author_sort Miyakawa, Kei
collection PubMed
description
format Online
Article
Text
id pubmed-9052787
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.
record_format MEDLINE/PubMed
spelling pubmed-90527872022-05-02 Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids Miyakawa, Kei Machida, Masakazu Kawasaki, Tomoyuki Nishi, Mayuko Akutsu, Hidenori Ryo, Akihide Gastroenterology Research Letter The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. 2022-08 2022-04-29 /pmc/articles/PMC9052787/ /pubmed/35500619 http://dx.doi.org/10.1053/j.gastro.2022.04.043 Text en © 2022 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Research Letter
Miyakawa, Kei
Machida, Masakazu
Kawasaki, Tomoyuki
Nishi, Mayuko
Akutsu, Hidenori
Ryo, Akihide
Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title_full Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title_fullStr Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title_full_unstemmed Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title_short Reduced Replication Efficacy of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in “Mini-gut” Organoids
title_sort reduced replication efficacy of severe acute respiratory syndrome coronavirus 2 omicron variant in “mini-gut” organoids
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052787/
https://www.ncbi.nlm.nih.gov/pubmed/35500619
http://dx.doi.org/10.1053/j.gastro.2022.04.043
work_keys_str_mv AT miyakawakei reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids
AT machidamasakazu reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids
AT kawasakitomoyuki reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids
AT nishimayuko reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids
AT akutsuhidenori reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids
AT ryoakihide reducedreplicationefficacyofsevereacuterespiratorysyndromecoronavirus2omicronvariantinminigutorganoids